Drinabant
≥99%
- Product Code: 179353
CAS:
358970-97-5
| Molecular Weight: | 497.38 g./mol | Molecular Formula: | C₂₃H₂₀Cl₂F₂N₂O₂S |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C |
Product Description:
Drinabant is primarily investigated for its potential in treating obesity and related metabolic disorders due to its action as a cannabinoid receptor type 1 (CB1) antagonist. By blocking CB1 receptors in the central nervous system and peripheral tissues, it helps regulate appetite and energy balance, leading to reduced food intake and weight loss. It has also shown promise in improving lipid profiles and insulin sensitivity, suggesting benefits in managing dyslipidemia and type 2 diabetes. Additionally, research explores its use in substance abuse disorders, particularly in reducing cravings and relapse in nicotine and alcohol dependence. However, due to concerns over psychiatric side effects linked to central CB1 blockade, development has focused on peripherally acting analogs to maintain efficacy with improved safety.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 5mg | 10-20 days | ฿15,900.00 |
+
-
|
| 25mg | 10-20 days | ฿41,700.00 |
+
-
|
Drinabant
Drinabant is primarily investigated for its potential in treating obesity and related metabolic disorders due to its action as a cannabinoid receptor type 1 (CB1) antagonist. By blocking CB1 receptors in the central nervous system and peripheral tissues, it helps regulate appetite and energy balance, leading to reduced food intake and weight loss. It has also shown promise in improving lipid profiles and insulin sensitivity, suggesting benefits in managing dyslipidemia and type 2 diabetes. Additionally, research explores its use in substance abuse disorders, particularly in reducing cravings and relapse in nicotine and alcohol dependence. However, due to concerns over psychiatric side effects linked to central CB1 blockade, development has focused on peripherally acting analogs to maintain efficacy with improved safety.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :